One-pot synthesis of benzotriazoles and benzotriazole 1-oxides by reductive cyclization of o-nitrophenylazo compounds with benzyl alcohol

Article abstract of DOI:10.3987/COM-09-11759

Reductive cyclization of 2-[(2-nitrophenyl)azophenols 1 with benzyl alcohol and sodium hydroxide afforded 2-(2H-benzotriazol- 2-yl)phenols 3 and their 1-oxide 2 in good to excellent yields.

Full text of DOI:10.3987/COM-09-11759

HETEROCYCLES, Vol. 78, No. 10, 2009
2579
HETEROCYCLES, Vol. 78, No. 10, 2009, pp. 2579 - 2588. © The Japan Institute of Heterocyclic Chemistry
Received, 18th May, 2009, Accepted, 18th June, 2009, Published online, 19th June, 2009
DOI: 10.3987/COM-09-11759
ONE-POT
SYNTHESIS
OF
BENZOTRIAZOLES
AND
BENZOTRIAZOLE 1-OXIDES BY REDUCTIVE CYCLIZATION OF
o-NITROPHENYLAZO COMPOUNDS WITH BENZYL ALCOHOL
Renata Farkas,a Mercedes Törincsi,a Pal Kolonits,a Oscar Jimenez Alonso,b
and Lajos Novak*a
aDepartment of Organic Chemistry and Technology, Budapest University of
Technology and Economics, Research Group for Alkaloid Chemistry, Hungarian
Academy of Sciences, Gellért tér 4, 1111 Budapest, Hungary
Fax +36 (1)4633297; E-mail: lnovak@mail.bme.hu
bISDIN, Diagonal 520, 08006 Barcelona, Spain
Abstract - Reductive cyclization of 2-[(2-nitrophenyl)azophenols 1 with benzyl
alcohol and sodium hydroxide afforded 2-(2H-benzotriazol- 2-yl)phenols 3 and
their 1-oxide 2 in good to excellent yields.
Benzotriazole derivatives serve as important precursor for the construction of heterocyclic ring systems.1-6
Many of them have significant pharmaceutical activities.7-9 The others have been used as building block
for the preparation of UV light absorbers.10-14
For the preparation of benzotriazole derivatives, the most frequently used method is the reductive
cyclization of o-nitroazobenzene derivatives (Scheme 1). The following reducing agents have been used:
powdered zinc and NaOH in an aqueous MeOH,15 hydrazine hydrate in the presence of NaOH,16,17
catalytic hydrogenation over palladium on charcoal18-21 or platinum sulfide on carbon22 or on modified
Raney Nickel,23,24 with electrolytic reduction at a mercury electrode,25 and formamidine sulfinic acid, and
baker’s yeast.27
The corresponding N-oxide 2 was an intermediate of the above reaction and could be prepared by the
reduction of o-nitroazobenzene with glucose in alcoholic NaOH,28 or with a mixture of sodium
hydrosulfide and NaOH in toluene and water,29 or with hydrazine hydrate in aqueous MeOH containing
2,3-dichloro-1,4-naphthoquinone.30 The method using baker’s yeast is also applicable for the preparation
of N-oxide.27

2580
HETEROCYCLES, Vol. 78, No. 10, 2009
In the course of developing novel scaffolds for medicinal and light absorbers application, we found that
2-aryl-2H-benzotriazoles 2, 3 could be prepared from o-nitroazobenzene 1 without using any of the above
listed reducing agents. Here we report in full experimental details of the new procedure and the related
spectral data.
Our preparations of compounds 2 and 3 were based on the reducing properties of benzyl alcohol under
o
basic condition. Treatment of a solution of azo compound 1a in benzyl alcohol with NaOH at 80 C
afforded rather fast formation of the corresponding N-oxide 2a and after 1.5 h this compound was isolated
o
in good yield (Table 1, entry 1). However, when the reaction was performed at 150 C, the initially
formed N-oxide was transformed into benzotriazole 3a which was then isolated in excellent yield (entry
2).
OH
HO
N
N N
NO2
b
a
N
N
O
X
X
R
R
2
1
HO
N
N
N
X
R
3
Scheme 1. Reagents: (a) benzyl alcohol, NaOH, t < 100oC;
(b) benzyl alcohol, NaOH, t > 120oC
To explore the scope and versatility of this method the effect of various substituents on the benzotriazole
skeleton and on the phenyl group were investigated.
As it can be seen in Table 1, neither the substitution of the benzotriazole (entries 7-12 and 13-16), nor the
substituent of the phenyl group (entries 3-6, 9-12, and 13-16) affected significantly the yield of the
reductive cyclization. In all cases, we got good or excellent yields.
In the above reactions benzyl alcohol acts as reducing agent. Namely, the process starts with single
electron transfer from the oxygen to the nitro group and then proceeds according to the known reduction
reactions of this group.
In summary, we have demonstrated that 2-aryl-2H-benzotriazoles can be prepared conveniently from
readily available o-nitroazobenzene without using expensive reducing agents. This new method has the
potential to be used in the synthesis of many other derivatives of benzotriazoles.

HETEROCYCLES, Vol. 78, No. 10, 2009
2581
Table 1 Compounds Prepared by the Reduction of 1a-h
Entry Substrate Product
X
H
R
Temp Time TLC
Mp
(oC)
Yielda
(%)
(oC)
80
(h)
1.5
Rf
143-45
1
2
1a
1a
1b
1b
1c
1c
1d
1d
1e
1e
1f
2a
3a
2b
3b
2c
3c
2d
3d
2e
3e
2f
Me
0.45
90
126-28
169-70
153-55
149-51
134-36
173-75
146-48
176-78
136-39
131-33
117-18
133-35
126-27
178-80
118-24
H
Me
150
80
1
0.79
0.38
0.70
0.42
0.85
0.51
0.80
0.47
0.73
0.50
0.88
0.33
0.75
0.43
0.66
95
81
98
80
81
52
87
61
74
75
79
69
57
75
80
3
H
Ph
1.5
4
4
H
Ph
cyclohexyl
cyclohexyl
Me
185
120
150
80
5
H
15
0.5
2.5
1
6
H
7
Cl
8
Cl
Me
150
80
9
Cl
Ph
1.5
1
10
11
12
13
14
15
16
Cl
Ph
150
80
Cl
cyclohexyl
cyclohexyl
Me
1.5
1.5
1.5
1
1f
3f
Cl
150
80
1g
1g
1h
1h
2g
3g
2h
3h
MeO
MeO
MeO
MeO
Me
150
120
140
Ph
1.5
1.5
Ph
aIsolated and unoptimized yields.
EXPERIMENTAL
Mps were determined on a Büchi apparatus and are uncorrected. IR spectra were recorded on Bruker
Alpha FT Spectrophotometer. 1H and 13C NMR spectra were obtained on a Bruker DRX-500
spectrometer. All NMR spectra are reported in ppm relative to TMS. Merck precoated silica gel 60 F254

2582
HETEROCYCLES, Vol. 78, No. 10, 2009
plates were used for TLC and Kieselgel 60 for column chromatography. A hexane-acetone 5:2 (v/v)
mixture was used for TLC.
Preparation of N-oxides 2; General Procedure
To a stirred solution of 1 (16 mmol) in freshly distilled benzyl alcohol (60 mL) was added pulverized
NaOH (0.7 g, 18 mmol) and the resulting mixture was heated with stirring at the temperature and for the
time given in Table 1. After cooling, water was added (25 mL), the mixture was acidified by the addition
of 2N aqueous HCl and then extracted with CH2Cl2 (3x25 mL). The combined organic layers were dried
(MgSO4), concentrated in vacuum and the residue was dried under IR lamp.
Preparation of Benzotriazoles 3; General Procedure
To a stirred solution of 1 (20 mmol) in freshly distilled benzyl alcohol (60 mL) was added NaOH powder
(1.4 g, 35 mmol) and the resultant mixture was heated with stirring at the temperature and for the time
given in Table 1. Evaporation of benzyl alcohol under reduced pressure provided a residue which was
treated with water. The solids were collected by filtration and then washed successively with water and
EtOH.
2-(2H-1,2,3-Benzotriazol-2-yl)-4-methylphenol (2a)31
IR (KBr): 3442 (OH), 1520, 1454, 1360, 1233, 1113 cm-1.
1H NMR (CDCl3): δ = 2.38 (s, 3H, CH3), 7.13 (d, J= 8.5 Hz, 1H, C6-H), 7.30 (dd, J= 8.5 and 1 Hz, 1H,
C5-H), 7.47 (t, J= 8 Hz, 1H, C6’-H), 7.52 (t, J= 8 Hz, 1H, C5’-H), 7.57 (br. s, 1H, C3-H), 7.82 (d, J= 8.5
Hz, 1H, C7’-H), 7.84 (d, J= 8.5 Hz, 1H, C4’-H), 9.77 (s, 1H, OH).
13C NMR (CDCl3): δ = 20.37 (CH3), 113.27 (C-7’), 119.25 (C-4’), 121.17 (C-6), 124.95 (C-2), 126.09
(C-3), 126.48 (C-7a’), 127.94 (C-6), 129.26 (C-5’), 131.01 (C-4), 133.61 (C-5), 142.20 (C-3a’), 149.82
(C-1).
3-(1-Oxido-2H-1,2,3-benzotriazol-2-yl)-3-biphenylol (2b)
IR (KBr): 3441 (OH), 1615, 1520, 1449, 1381, 1298, 1114 cm-1.
1H NMR (CDCl3): δ = 7.31 (d, J= 8.5 Hz, 1H, C5-H), 7.35 (t, J= 7.5 Hz, 1H, C10-H), 7.44 (t, J= 7.5 Hz,
2H, C9-H and C11-H), 7.50 (t, J= 8 Hz, 1H, C6’-H), 7.54 (m-t, J= 8 Hz, 1H, C5’-H), 7.60 (d, J= 7.5 Hz, 2H,
C8-H and C12-H), 7.74 (d, J= 8.5 Hz, 1H, C6-H), 7.85 (d, J= 8.3 Hz, 1H, C7’-H), 7.87 (d, J= 8.6 Hz, 1H,
C4’-H), 8.01 (s, 1H, C2-H), 10.12 (s, 1H, OH).
13C NMR (CDCl3): δ = 113.30 (C-7’), 119.35 (C-4’), 121.81 (C-5), 124.66 (C-2), 125.63 (C-3), 126.59
(C-7a’), 126.86 (C-8 and C-12), 127.46 (C-10), 128.51 (C-6’), 128.91 (C-9 and C-11), 129.41 (C-5’),
131.39 (C-6), 134.78 (C-1), 139.28 (C-7), 142.36 (C-3a’), 151.43 (C-4).
Anal. Calcd for C18H13N3O2: C, 71.28; H, 4.32; N, 13.85. Found: C, 71.04; H, 4.55; N, 13.67.

HETEROCYCLES, Vol. 78, No. 10, 2009
2583
4-Cyclohexyl-2-(1-oxido-2H-1,2,3-benzotriazol-2yl)phenol (2c)
IR (KBr): 3442 (OH), 1614, 1505, 1457, 1388, 1254, 1105 cm-1.
1H NMR (CDCl3): δ = 1.26 (m, 1H, C4”-H), 1.41 (m, 2H, C3”-H and C5”-H), 1.43 (m, 2H, C2”-H and
C6”-H), 1.75 (m, 1H, C4”-H), 1.85 (m, 2H, C3”-H and C5”-H), 1.92 (m, 2H, C2”-H and C6”-H), 2.56 (m, 1H,
C1”-H), 7.00 (br.s, 1H, OH), 7.16 (d, J= 8.4 Hz, 1H, C6-H), 7.36 (d, J= 8.4 Hz, 1H, C5-H), 7.49 (t, J= 8.0
Hz, 1H, C6’-H), 7.53 (t, J= 8.0 Hz, 1H, C5’-H), 7.60 (s, 1H, C3-H), 7.84 (d, J= 8.6 Hz, 1H, C7’-H), 7.87 (d,
J= 8.8 Hz, 1H, C4’-H).
13C NMR (CDCl3): δ = 26.03 (C-4”), 26.79 (C-3” and C-5”), 34.51 (C-2” and C-6”), 43.56 (C-1”), 113.30
(C-7’), 119.29(C-4’), 121.21 (C-6), 124.11 (C-3), 125.04 (C-2), 126.53 (C-7a’), 127.94 (C-6’), 129.23
(C-5’), 131.49 (C-5), 141.49 (C-4), 142.22 (C-3a’), 149.98 (C-1).
Anal. Calcd for C18H19N3O2: C, 69.88; H, 6.19; N, 13.58. Found: C, 70.11; H, 6.34, N, 13.36.
2-(6-Chloro-1-oxido-2H-1,2,3-benzotriazol-2-yl)-4-methylphenol (2d)28
IR (KBr): 3441 (OH), 1616, 1509, 1498, 1362, 1254, 1123 cm-1.
1H NMR (CDCl3): δ = 2.38 (s, 3H, CH3), 7.13 (d, J= 8.4 Hz, 1H, C6-H), 7.32 (dd, J= 8.4 and 1.0 Hz,
1H, C5-H), 7.46 (dd, J= 8.4 and 1.5 Hz, 1H, C5’-H), 7.54 (br. s, 1H, C3-H), 7.80 (d, J= 9.2 Hz, 1H, C4’-H),
7.84 (br. s, 1H, C7’-H), 9.26 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 20.38 (CH3), 112.47 (C-7’), 120.53 (C-4’), 121.31 (C-6), 124.81 (C-2), 126.01
(C-3), 126.58 (C-7a’), 131.10 (C-5’), 131.19 (C-4), 133.81 (C-5), 134.28 (C-6’), 140.58 (C-3a’), 149.79
(C-1).
3-(6-Chloro-1-oxido-2H-1,2,3-benzotriazol-2-yl)-4-biphenylol (2e)
IR (KBr): 3440 (OH), 1500, 1447, 1358, 1233, 1121 cm-1.
1H NMR (CDCl3): δ = 7.31 (d, J= 8.6 Hz, 1H, C5-H), 7.36 (t, J= 7.2 Hz, 1H, C10-H), 7.45 (t, J= 7.2 Hz,
2H, C9-H and C11-H), 7.47 (d, J= 7.9 Hz, 1H, C5’-H), 7.60 (dd, J= 8.5 and 1 Hz, 2H, C8-H and C12-H),
7.76 (dd, J= 8.5 and 2 Hz, 1H, C5-H), 7.82 (d, J= 9.1 Hz, 1H, C4’-H), 7.88 (br. s, 1H, C7’-H), 7.98 (d, J= 2
Hz, 1H, C2-H), 9.89 (s, 1H, OH).
13C NMR (CDCl3): δ = 112.49 (C-7’), 120.62 (C-4’), 121.94 (C-5), 124.58 (C-2), 125.49 (C-3), 126.70
(C-7a’), 126.88 (C-8 and C-12), 127.57 (C-10), 128.96 (C-9 and C-11), 131.28 (C-5’), 131.67 (C-6),
134.56 (C-6), 134.98 (C-1), 139.18 (C-7), 140.74 (C-3a’), 151.38 (C-4).
Anal. Calcd for C18H12ClN3O2: C, 64.01; H, 3.58; N, 12.44. Found: C, 63.92; H, 3.77, N, 12.21.
2-(6-Chloro-1-oxido-2H-1,2,3-benzotriazol-2-yl)-4-cyclohexylphenol (2f)
IR (KBr): 3440 (OH), 1500, 1447, 1358, 1233, 1121 cm-1.
1H NMR (CDCl3): δ = 1.26 (m, 1H, C4”-H), 1.40 (m, 2H, C3”-H and C5”-H), 1.42 (m, 2H, C2”-H and
C6”-H), 1.75 (m, 2H, C4”-H), 1.86 (m, 2H, C3”-H and C5”-H), 1.91 (m, 2H, C2”-H and C6”-H), 2.55 (m, 1H,
C1”-H), 7.15 (d, J= 8.5 Hz, 1H, C6-H), 7.37 (d, J= 8.2 Hz, 1H, C5-H), 7.46 (d, J= 9.1 Hz, 1H, C5’-H), 7.56

2584
HETEROCYCLES, Vol. 78, No. 10, 2009
s, 1H, C3-H), 7.81 (d, J= 9.1 Hz, 1H, C4’-H), 7.85 (s, 1H, C7’-H), 8,0 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 26.41 (C-4”), 27.17 (C-3” and C-5”), 34.90 (C-2” and C-6”), 43.93 (C-1”), 112.87
(C-7’), 120.94 (C-4’), 121.71 (C-6), 124.41 (C-3), 125.28 (C-2), 127.00 (C-7a’), 131.45 (C-5’), 132.17
(C-5), 134.65 (C-6’), 140.96 (C-3a’), 142.03 (C-4), 150.36 (C-1).
Anal. Calcd for C18H18ClN3O2: C, 62.88; H, 5.28; N, 12.22. Found: C, 62.59; H, 5.02; N, 12.49.
2-(6-Methoxy-1-oxido-2H-1,2,3-benzotriazol-2-yl)-4-methylphenol (2g)
IR (KBr): 3441 (OH), 1632, 1529, 1511, 1469, 1341, 1275, 1225, 1114 cm-1.
1H NMR (CDCl3): δ = 2.38 (s, 3H, CH3), 3.94 (s, 3H, OCH3), 6.98 (d, J= 1.7 Hz, 1H, C7’-H), 7.12 (d, J=
8.4 Hz, 1H, C6-H), 7.19 (dd, J= 9.4 and 2.2 Hz, 1H, C5’-H), 7.29 ((d, J= 8.5 Hz, 1H, C5-H), 7.52 (s, 1H,
C3-H), 7.71 (d, J= 9.4 Hz, 1H, C4’-H), 10.00 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 20.39 (CH3), 56.14 (OCH3), 89.71 (C-7’), 120.28 (C-4’), 121.14 (C-6), 124.93
(C-5’), 125.23 (C-2), 125.91 (C-3), 127.27 (C-7a’), 130.89 (C-4), 133.29 (C-5), 138.89 (C-3a’), 149.74
(C-1), 160.15 (C-6’).
Anal. Calcd for C14H13N3O3: C, 61.99; H, 4.83; N, 15.49. Found: C, 62.21; H, 4.63; N, 15.25.
3-(6-Methoxy-1-oxydo-2H-1,2,3-benzotriazol-2-yl)-4-biphenylol (2h)
IR (KBr): 3440 (OH), 1632, 1620, 1526, 1488, 1378, 1285, 1224, 1014 cm-1.
1H NMR (CDCl3): δ = 3. 59 (s, 3H, OCH3), 6.99 (s, 1H, C7’-H), 7.19 (dd, J= 9.4 and 1.7 Hz, 1H, C5’-H),
7.29 (d, J= 8.5 Hz, 1H, C5-H), 7.35 (t, J= 7.4 Hz, 1H, C10-H), 7.44 (t, J= 7.5 Hz, 2H, C9-H and C11-H),
7.60 (d, J= 7.7 Hz, 2H, C8-H and C12-H), 7.71 (dd, J= 8.4 and 1.6 Hz, 1H, C6-H), 7.73 (d, J= 9.4, 1H,
C4’-H), 7.95 (s, 1H, C2-H), 8.00 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 56.16 (OCH3), 89.63 (C-7’), 120.34 (C-4’), 121.72 (C-5), 124.47 (C-2), 125.08
(C-5’), 125.86 (C-3), 126.85 (C-8 and C-12), 127.40 (C-7a’), 128.90 (C-9 and C-11),131.05 (6), 134.63
(C-1), 139.02 (C-3a’), 139.37 (C-7), 151.36 (C-4), 160.30 (C-6’).
Anal. Calcd for C19H15N3O3: C, 68.46; H, 4.54; N, 12.61. Found: C, 68.52; H, 4.43; N, 12. 82.
2-(2H-1,2,3-Benzotriazol-2-yl)-4-methoxyphenol (3a)31
IR (KBr): 3441 (OH), 1615, 1599, 1514, 1473, 1348, 1304, 1251, 1131 cm-1.
1H NMR (CDCl3): δ = 2.41 (s, 3H, CH3), 7.09 (d, J= 8.4 Hz, 1H, C6-H), 7.16 (d, J= 8.4 Hz, 1H, C5-H),
7.49 (dd, J= 8.4 and 3.0 Hz, 2H, C5’-H and C6’-H), 7.94 (dd, J= 6.6 and 3.0 Hz, 2H, C4’-H and C7’-H),
8.22 (s, 1H, C3-H), 11.11 (s, 1H, OH).
3-(2H-1,2,3-Benzotriazol-2-yl)-4-biphenylol (3b)11
IR (KBr): 3441 (OH), 1615, 1596, 1484, 1355, 1225, 1133 cm-1.
1H NMR (CDCl3): δ = 7.27 (d, J= 8.5 Hz, 1H, C5-H), 7.35 (t, J= 7.3 Hz, 1H, C10-H), 7.46 (t, J= 7.5 Hz,
2H, C9-H and C11-H), 7.49 (dd, J= 6.5 and 3.0 Hz, 2H, C5’-H and C6’-H), 7.59 (d, J= 8.5 Hz, 1H, C5-H),
7.66 (d, J= 7.5 Hz, 2H, C8-H and C12-H), 7.93 (dd, J= 6.5 and 3.0 Hz, 2H, C4’-H and C7’-H), 8.65 (d, J=

HETEROCYCLES, Vol. 78, No. 10, 2009
2585
1.8 Hz, 1H, C2-H), 11.37 (s, 1H, OH).
13C NMR (CDCl3): δ = 117.71 (C-4’ and C-7’), 119.42 (C-5), 119.48 (C-2), 125.44 (C-3), 126.79 (C-8),
127.24 (C-10), 127.81 (C-5’ and C-6’), 128.86 (C-9 and C-11), 129.04 (C-6), 133.48 (C-1), 139.72 (C-7),
142.87 (C-3a’ and C-7a’), 149.17 (C-4).
2-(2H-1,2,3-Benzotriazol-2-yl)-4-cyclohexylphenol (3c)11
IR (KBr): 3442 (OH), 1616, 1595, 1515, 1448, 1351, 1254, 1220, 1132 cm-1.
1H NMR (CDCl3): δ = 1.29 (m, 1H, C4”-H), 1.43 (m, 2H, C3”-H and C5”-H), 1.47 (m, 2H, C2”-H and
C6”-H), 1.76 (d, J= 12.5 Hz, 1H, C4”-H), 1.86 (d, J= 12.5 Hz, 2H, C3”-H and C5”-H), 1.94 (d, J= 12.5 Hz,
2H, C2”-H and C6”-H), 2.57 (m, 1H, C1”-H), 7.12 (d, J= 8.5 Hz, 1H, C6-H), 7.20 (dd, J= 8.5 and 0.9 Hz,
1H, C5-H ), 7.47 (dd, J= 6.5 and 2.9 Hz, 2H, C5’-H and C6’-H), 7.93 (dd, J= 6.5 and 2.9 Hz, 2H, C4’-H and
C7’-H), 8.24 (d, J= 0.8 Hz, 1H, C3-H ), 11.13 (s, 1H, OH).
13C NMR (CDCl3): δ = 26.09 (C-4”), 26.88 (C-3” and C-5”), 34.58 (C-2” and C-6”), 43.74 (C-1”),
117.67 (C-4’ and C-7’), 118.75 (C-6), 119.03 (C-3), 124.95 (C-2), 127.61 (C-5’ and C-6’), 129.12 (C-5),
140.20 (C-4), 142.81 (C-3a’ and C-7a’), 147.75 (C-1).
2-(5-Chloro-2H-1,2,3-benzotriazol-2-yl)-4-methylphenol (3d)28
IR (KBr): 3442 (OH), 1618, 1596, 1516, 1383,1236,1053 cm-1.
1H NMR (CDCl3): δ = 2.38 (s, 3H, CH3), 7.07 (d, J= 8.3 Hz, 1H, C6-H), 7.14 (d, J= 8.3 Hz, 1H, C5-H),
7.40 (dd, J= 8.1 and 0.9 Hz, 1H, C5’-H), 7.84 (d, J= 8.8 Hz, 1H, C4’-H), 7.88 (s, 1H, C7’-H), 8.12 (s, 1H,
C3-H), 10.83 (s, 1H, OH).
13C NMR (CDCl3): δ = 20.53 (CH3), 116.65 (C-7’), 118.77 (C-4’), 118.85 (C-6), 121.09 (C-3), 124.60
(C-2), 129.18 (C-5’), 129.77 (C-4), 131.62 (C-5), 133.53 (C-6’), 141.29 (C-3ª’), 143.12 (C-7ª’), 147.48
(C-1).
3-(5-Chloro-2H-1,2,3-benzotriazol-2-yl)-4-biphenylol (3e)
IR (KBr): 3442 (OH), 1613, 1593, 1482, 1391, 1242, 1057 cm-1.
1H NMR (CDCl3): δ = 7.26 (d, J= 8.1 Hz, 1H, C5-H), 7.36 (d, J= 7.5 Hz, 1H, C10-H), 7.43 (dd, J= 9.0 and
1.0 Hz, 1H, C6’-H), 7.46 (t, J= 8.0 Hz, 2H, C9-H and C11-H), 7.60 (dd, J= 8.5 and 2.0 Hz, 1H, C6-H), 7.65
(d, J= 7.6 Hz, 2H, C8-H and C12-H), 7.88 (d, J= 9.1 Hz, 1H, C7’-H), 7.93 (d, J= 1.0 Hz, 1H, C4’-H), 8.61
(d, J= 2.0 Hz, 1H, C2-H), 11.10 (s, 1H, OH).
13C NMR (CDCl3): δ = 116.73 (C-4’), 118.87 (C-7’), 119.50 (C-5), 119.54 (C-2), 125.24 (C-3), 126.78
(C-8 and C-12), 127.33 (C-10), 128.90 (C-9 and C-11), 129.40 (C-6 and C-6’), 133.62 (C-1), 133.75
(C-5’), 139.59 (C-7), 141.39 (C-7a’), 143.22 (C-3a’), 149.12 (C-4).
Anal. Calcd for C18H12ClN3O: C, 67.19; H, 3.76; N, 13.06. Found: C, 67.02; H, 3.58; N, 13.01.
2-(5-Chloro-2H-1,2,3-benzotriazol-2-yl)-4-cyclohexylphenol (3f)
IR (KBr): 3440 (OH), 1618, 1596, 1449, 1348, 1253, 1048 cm-1.

2586
HETEROCYCLES, Vol. 78, No. 10, 2009
1H NMR (CDCl3): δ = 1.28 (m, 1H, C4”-H), 1.43 (m, 2H, C3”-H and C5”-H), 1.47 (m, 2H, C2”-H and
C6”-H), 1.77 (m, 1H, C4”-H), 1.87 (m, 2H, C3”-H and C5”-H), 1.93 (m, 2H, C2”-H and C6”-H),2.57 (m, 1H,
C1”-H), 7.11 (d, J= 8.4 Hz, 1H, C6’-H), 7.21 (d, J= 8.0 Hz, 1H, C5-H), 7.42 (d, J= 9.0 Hz, 1H, C5’-H), 7.87
(d, J= 9.0 Hz, 1H, C4’’-H), 7.93 (s, 1H, C7’-H), 8.20 (s, 1H, C3-H), 10.88 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 26.07 (C-4”), 26.85 (C-3” and C-5”), 34.56 (C-2” and C-6”), 43.71 (C-1”), 116.69
(C-7’), 118.83 (C-4’), 118.87 (C-6), 119.04 (C-3), 124.76 (C-2), 129.19 (C-5’), 129.52 (C-5), 133.53
(C-6’), 140.36 (4), 141.34 (C-3a’), 143.17 (C-7a’), 147.72 (C-1).
Anal. Calcd for C18H18ClN3O: C, 65.95; H, 5.53; N, 12.82. Found: C, 66.13; H, 5.32; N, 12.59.
2-(5-Methoxy-2H-1,2,3-benzotriazol-2-yl)-4-methylphenol (3g)11
IR (KBr): 3441 (OH), 1630, 1521, 1437, 1302, 1228, 1123, 1026 cm-1.
1H NMR (CDCl3): δ = 2.31 (s, 3H, CH3), 3.88 (s, 3H, OCH3), 7.05 (d, J= 8.0 Hz, 1H, C6-H), 7.17 (d, J=
9.0 Hz, 1H, C6’-H), 7.19 (d, J= 9.0 Hz, 1H, C5-H), 7.33 (s, 1H, C4’-H), 7.67 (s, 1H, C3-H), 7.91 (d, J= 9.0
Hz, 1H, C7’-H), 10.40 (br. s, 1H, OH).
13C NMR (CDCl3): δ = 20.07 (CH3), 55.88 (OCH3), 95.06 (C-4’), 118.10 (C-6), 118.96 (C-7’), 122.28
(C-6’), 124.24 (C-3), 126.58(C-2), 128.50 (C-4), 131.28 (C-5), 139.61 (C-7a’), 144.58 (C-3a’), 148.2
(C-1), 159.10 (C-5’).
3-(5-Methoxy-2H-1,2,3-benzotriazol-2-yl)-4-biphenylol (3h)
IR (KBr): 3450 (OH), 1624, 1614, 1500, 1310, 1140 cm-1.
1H NMR (CDCl3): δ = 3.89 (s, 3H, OCH3), 7.10 (s, 1H, C4’-H), 7.13 (d, J= 9.2 Hz, 1H, C6’-H), 7.23 (d, J=
8.6 Hz, 1H, C5-H), 7.34 (t, J= 7.3 Hz, 1H, C10-H), 7.44 (t, J= 7.5 Hz, 2H, C9-H and C11-H), 7.54 (d, J=
8.6 Hz, 1H, C6-H), 7.65 (d, J= 7.5 Hz, 2H, C8-H and C12-H), 7.77 (d, J= 9.2 Hz, 1H, C7’-H), 8.56 (s, 1H,
C2-H), 11.31 (s, 1H, OH).
13C NMR (CDCl3): δ = 55.64 (OCH3), 94.17 (C-4’), 118.46 (C-7’), 118.99 (C-2), 119.25 (C-5), 122.98
(C-6’), 125.53 (C-3), 126.76 (C-8 and C-12), 127.15 (C-10), 128.40 (C-6), 128.82 (C-9 and C-11), 133.33
(C-1), 139.02 (C-7a’), 139.81 (C-7), 143.94 (C-3a’), 148.74 (C-4), 159.81 (C-5’).
Anal. Calcd for C19H15N3O2: C, 71.91; H, 4.76; N, 13.24. Found: C, 71.70; H, 4.55; N, 13.31.
ACKNOWLEDGEMENT
The financial support for this investigation was provided by ISDIN. S. A. (Barcelona, Spain) and is
greatly appreciated.
REFERENCES
1. K. H. Saunders and R. L. M. Allen, ’Aromatic Diazo Compounds’, E. Arnold Ltd. London, 3rd ed,
1985.

HETEROCYCLES, Vol. 78, No. 10, 2009
2587
2. A. F. Hegarty,
̔
̕
, ed. by S. Patai, Part 2, John Wiley &
Sons, New York, 1978, pp. 545-551.
3. I. Szele and H. Zollinger, Topics in Current Chemistry, 1983, 112, 1; J. R Penton, Helv. Chim. Acta,
1982, 65, 122; D. Bahulayan, L. John, and M. Lalithambika, Synth. Commun., 2003, 33, 863; H. A.
Dabbagh, A. Teimouri, and A. N. Chermahini, Dyes and Pigments, 2007, 73, 239; and references
cited therein.
4. A. R. Katritzky, S. Rachwal, and G. J. Hitchings, Tetrahedron, 1991, 47, 2683.
5. A. R. Katritzky, X. Lan, J. Z. Yang, and O. Denisko, Chem. Rev., 1998, 98, 409.
6. A. R. Katritzky, J. Heterocycl. Chem., 1999, 36, 1501.
7. G. Scapin, S. B. Patel, J. W. Becker, Q. Wang, C. Desponts, D. Waddleton, K. Skorey, W. Cromlish,
Ch. Bayly, and M. Therien, Biochemistry, 2003, 42, 11451.
8. P. G. Baraldi, R. Makaeva, M. G. Pavani, M. Del Carmen Nunez, G. Spallato, S. Moro, S. Falzoni, F.
DiVirgilio, and R. Romagnoli, Arzneimittel-Forschung, 2002, 52, 273.
9. F. Al-Omran, R. M. Mohareb, M. Rafat, and A. A. El-Khair, J. Heterocycl. Chem., 2002, 39, 877.
10. A. G. Koutsimpelis, C. G. Screttas, and O. Igglessi-Markopoulou, Heterocycles, 2005, 65, 1393.
11. C. Trullas, C. Pelejero, J. Corbera, O. Jimenez, and L. Novak, Spain Pat. Appl., (2008), ES 2300199
A1 20080601.
12. K. Golz-Berner, L. Zastrow, and S. Miton, Ger. Pat. Appl., (2008), DE 102007010861 A1 20080904.
13. E. Woldt and S. Schmidt, U.S. Pat. Appl., (2006), US 2006084754 A1 20060420.
14. A. Goeppel, Eur. Pat. Appl., (2003), EP 1308153 A2 20030507.
15. M. F. Bruno, US Patent, 3018269 (1962) (Chem. Abstr., 1962, 57, 6147).
16. Ciba-Geigy AG, Fr. Demande, 2 292708 (1976) (Chem. Abstr., 1977, 86, 189953).
17. J. Rody and A. C. Rochat, German Patent, 2454889 (1975) (Chem. Abstr., 1975, 93, 8181).
18. A. C. Ziegler and, H. J. Peterli, Swiss Patent, 615165 (1980) (Chem. Abstr., 1980, 93, 8181).
19. S. Kintopf and U. Kress, German Patent, 2620970 (1976) (Chem. Abstr., 1977, 86, 89835).
20. K. Nakajima, T. Hiiro, and Y. Hukuda, Japan. Kokai, 1977, 77, 113974 (Chem. Abstr., 1978, 88,
105347).
21. C. E. Ziegler, Swiss Patent, 615166 (1980) (Chem. Abstr., 1980, 93, 8179).
22. E. H. Jancis, German Patent, 2455155 (1975) (Chem. Abstr., 1975, 83, 115994).
23. H. L. White and C. V. Krolewski, German Patent, 2620896 (1976) (Chem. Abstr., 1977, 86, 106598).
24. H. L. White and C. V. Krolewski, German Patent, 615167 (1980) (Chem. Abstr., 1980, 93, 8180).
25. R. Bourgeois, A. Delay, R. Hazard, and A. Tallec, Electrochim. Acta, 1977, 22, 857.
26. S. Tanimoto and T. Kamano, Synthesis, 1986, 647.
27. W. Baik, T. H. Park, B. H. Kim,and Y. M. Jun, J. Org. Chem., 1995, 60, 5883.

2588
HETEROCYCLES, Vol. 78, No. 10, 2009
28. J. Rosevear and J. F. K. Wilshire, Aust. J. Chem., 1982, 35, 2089.
29. J. Roberts and W. B. Hardy, U.S. Patent 4224451 (1980) (Chem. Abstr., 1981, 94, 121545).
30. Y. Wakisaka and M. Sumitani, Japan. Kokai, 78 63379 (1978) (Chem. Abstr., 1978, 89, 180008).
31. W. Baik, T. H. Park, R. H. Kim, and Y. M. Yun, J. Org. Chem., 1995, 60, 5683.